Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-03

Clinical Trial Update: Topical Pancreatic Duct Lidocaine for Prevention of Post-ERCP Pancreatitis [NA]

View source ↗

Summary

Clinical trial evaluating topical lidocaine applied to the pancreatic duct to prevent post-ERCP pancreatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: Abraham Mathew MD | Conditions: Pancreatitis | NA | Status: COMPLETED | Results posted: 2017-10-03